An artificial organ is a device which is man-made and is integrated or implanted into the human in order to restore target function via the replacement of a natural organ. The material used to develop body interfaces or implants are known as biomaterials. Processing abilities that are not occurring naturally can be constructed and installed with the help of artificial organs and replaced function need not be in the context of life support but generally, it is to support life. There is no necessity to bind artificial organ with stationary sources and stationary power supply for example chemical processing units and filters. The application and study of electronics and mechanics for replacing a limb or mechanically powered part of a functional organ is termed as medical bionics. Due to the rapid development in the field of biomedical science, organ transplantation has evolved as a common practice. For humans, new organs can be artificially grown in a lab known as in vitro, in vivo with the use of stem cells, xenotransplantation or in genetically modified animal and cyborgisation or built as a machine. Artificial organ market includes artificial ear, corpora cavernosa, cardiac and pylorus valves, brain, eye, artificial limbs, heart, bladder, pancreas, limbs, trachea, ovaries, ear, and others.
All artificial organs do not repair physical damage such as a brain pacemaker that helps in relieving epilepsy, neural network diseases and shivering of Parkinson’s disease. In spite of being expensive artificial organs are constructed and installed to support life and for the prevention of imminent death while waiting for a transplant, cosmetic restoration after accident and others. Research is in the process in the areas of information processing, memory, and vision. Researchers are currently working to make the bionic organs more permanent and are also commissioning on natural and sensory feel of the devices so that they may replicate original organs and instruments such as 3D printing of bionic organs, another type of organ such as artificial skin and others are expected to emerge in the coming future. There is the development of bionic orthopedics, bionic eye and exoskeleton only in specific regions because of more research in some regions as compared to others. Increase in prevalence of renal disorders and acute renal failure due to the faulty lifestyle of the general population followed by increase in organ failure because of age-related disorders and aging, increase in injuries and accidents which lead to amputations and rise in number of people for organ transplants are the drivers for the growth of the market.
Key product segments covered in this report includes artificial organs such as total artificial heart, artificial liver, artificial pancreas, artificial lungs, artificial kidney and bionics such as cochlear implants, exoskeletons, cardiac bionics, bionic limbs, brain bionics and vision bionics.
Key technology segments of artificial organ market are mechanical bionics and electronic bionics. There has been a great advancement in artificial organic or bionic implant industry in the past and because of the challenge of fulfilling unmet demands, the trend is expected to further rise. The focus of manufactures is on the development of organs such as bio-lung, wearable artificial kidney, and artificial pancreas.
Geographically, the global artificial vital organs and medical bionics market is categorized into North America, Europe, Asia-Pacific and Rest of the World (RoW) regions. North America held the largest share in the artificial organ or medical bionic implant space, followed by Europe. However, the market is emerging due to the rise in population coupled with awareness among the players and the patients. Growing income levels, increasing healthcare expenditure, less competition than mature countries are the factors which are responsible for increasing the market players’ interest in emerging markets. Asia-Pacific region is expected to rise and hold a larger share of this market in near future because of the rise in medical tourism, improvement in healthcare infrastructure and others.
Some of the key players of the artificial organ or bionic implant market include Abiomed Inc., Asahi Kasei Kuraray Medical Co. Ltd., Thoratec Corporation, WorldHeart Corp., Gambro AB, Biomet Inc., Cochlear Ltd, Berlin Heart Gmbh, Ekso Bionics, Medtronic Inc., Lifenet Health, Heartware International Inc. Jarvik Heart Inc. Walk Inc.Ossur, Boston Scientific Corporation, Sorin S.P.A., and others.
Avail customized purchase options to meet your research needs:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.